Related Experiment Video
Updated: Jan 26, 2026

Chemical Dimerization-Induced Protein Condensates on Telomeres
Published on: April 12, 2021
The D-dimer assay
Eric D Johnson1, John C Schell2, George M Rodgers1
1Division of Hematology and Hematologic Malignancies, University of Utah Health Sciences Center, Salt Lake City, Utah.
Abstract:
D-dimer is an indirect marker of fibrinolysis and fibrin turnover; this molecule exhibits unique properties as a biological marker of hemostatic abnormalities as well as an indicator of intravascular thrombosis. D-dimer is a soluble fibrin degradation product that results from the systematic degradation of vascular thrombi through the fibrinolytic mechanism. Because of this, the D-dimer serves as a valuable marker of activation of coagulation and fibrinolysis in a number of clinical scenarios. Most commonly, D-dimer has been extensively investigated for excluding the diagnosis of venous thromboembolism (VTE) and is used routinely for this indication. In addition, D-dimer has been evaluated for determining the optimal duration of anticoagulation in VTE patients, for diagnosing and monitoring disseminated intravascular coagulation, and for monitoring other conditions in which the patient is at high risk of bleeding or thrombosis. Limitations of the assay include D-dimer elevation in a constellation of clinical scenarios (age, pregnancy, and cancer) and lack of clinical standardization.
Insights
D-dimer testing is a valuable tool for diagnosing blood clots, particularly venous thromboembolism (VTE). While widely used to rule out VTE, its elevation in conditions like cancer requires careful interpretation.
Area of Science:
- Biochemistry
- Hematology
- Medical Diagnostics
Background:
- D-dimer is a fibrin degradation product reflecting fibrinolysis and fibrin turnover.
- It serves as a marker for hemostatic abnormalities and intravascular thrombosis.
- D-dimer indicates activation of coagulation and fibrinolysis in various clinical contexts.
Purpose of the Study:
- To explore the utility of D-dimer as a biomarker in clinical scenarios.
- To highlight its role in excluding venous thromboembolism (VTE).
- To discuss its application in managing anticoagulation, disseminated intravascular coagulation, and bleeding/thrombotic risks.
Main Methods:
- Review of existing literature and clinical investigations on D-dimer assays.
- Analysis of D-dimer's performance in diagnosing and monitoring thrombotic conditions.
- Evaluation of factors influencing D-dimer levels.
Main Results:
- D-dimer is routinely used to exclude the diagnosis of VTE.
- It is evaluated for optimizing anticoagulation duration in VTE patients.
- D-dimer aids in diagnosing and monitoring disseminated intravascular coagulation and other high-risk conditions.
Conclusions:
- D-dimer is a significant diagnostic marker for coagulation and fibrinolysis.
- Its primary application is in the exclusion of VTE.
- Limitations include non-specific elevation in age, pregnancy, cancer, and lack of standardization.
Related Concept Videos
Enzyme-Linked Immunosorbent Assay
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
Cooperative Binding of Transcription Regulators
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
The Nucleosome Core Particle
The paradox
Nucleosomes, paradoxically, perform two opposite functions simultaneously. On the one hand, their main responsibility is to protect the delicate DNA strands from physical damage and help achieve a higher compaction ratio. While on the other hand, they must allow polymerase enzymes to access DNA...
Inheritance of Chromatin Structures
Protein-protein Interfaces

